WATERGATE OFFICE TOWERS EMERYVILLE TOWER 1 EMERYVILLE, CALIFORNIA OFFICE LEASE AGREEMENT BETWEEN CA-EMERYVILLE PROPERTIES LIMITED PARTNERSHIP, a Delaware limited partnership (“LANDLORD”) AND NEUROMOLECULAR PHARMACEUTICALS, INC., a Delaware Corporation...Office Lease Agreement • March 5th, 2014 • Adamas Pharmaceuticals Inc • Pharmaceutical preparations
THIS OFFICE LEASE AGREEMENT (the “Lease”) is made and entered into as of October 25, 2006, by and between, CA-EMERYVILLE PROPERTIES LIMITED PARTNERSHIP, a Delaware limited partnership (“Landlord”) and NEUROMOLECULAR PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”). The following exhibits and attachments are incorporated into and made a part of the Lease: Exhibit A (Outline and Location of Premises), Exhibit B (Expenses and Taxes), Exhibit C (Intentionally Omitted), Exhibit D (Commencement Letter), Exhibit E (Building Rules and Regulations), Exhibit F (Additional Provisions), Exhibit G (Parking Agreement) and Exhibit H (Asbestos Notification).
ADAMAS PHARMACEUTICALS, INC. INDEMNITY AGREEMENTIndemnification Agreement • March 5th, 2014 • Adamas Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS AGREEMENT is made and entered into this , 2014 by and between ADAMAS PHARMACEUTICALS, INC., a Delaware corporation (the “Corporation”), and (“Agent”).
THIRD AMENDMENT TO LEASELease • March 5th, 2014 • Adamas Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS THIRD AMENDMENT TO LEASE (“Amendment”), dated for reference purposes only as of the 17 day of June, 2011, is entered into by and between EMERYVILLE OFFICE, L.L.C., a Delaware limited liability company (“Landlord”), and ADAMAS PHARMACEUTICALS, INC., a Delaware corporation (formerly known as Neuromolecular Pharmaceuticals, Inc.) (“Tenant”).
FIRST AMENDMENT TO LEASELease Agreement • March 5th, 2014 • Adamas Pharmaceuticals Inc • Pharmaceutical preparations
THIS FIRST AMENDMENT TO LEASE (this “First Amendment”) is entered into as of the twenty-ninth day of April, 2009, by and between NOP WATERGATE LLC, a Delaware limited liability company (“Landlord”), and ADAMAS PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
ADAMAS PHARMACEUTICALS, INC. FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT June 30, 2011Investors’ Rights Agreement • March 5th, 2014 • Adamas Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Fourth Amended and Restated Investors’ Rights Agreement (this “Agreement”) is made as of June 30, 2011, by and among Adamas Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and the persons and entities listed on Exhibit A hereto (each, an “Investor” and collectively, the “Investors” or “Preferred Holders”) and the persons and entities listed on Exhibit B hereto (each, a “Common Holder” and collectively, the “Common Holders”). Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.
SECOND AMENDMENT TO OFFICE LEASE AGREEMENTOffice Lease Agreement • March 5th, 2014 • Adamas Pharmaceuticals Inc • Pharmaceutical preparations
This SECOND AMENDMENT TO OFFICE LEASE AGREEMENT (“Amendment”), dated for reference purposes as of this 18 day of January, 2011, is by and between EMERYVILLE OFFICE, L.L.C., a Delaware limited liability company (“Landlord”) (as successor-in-interest to NOP WATERGATE LLC, a Delaware limited liability company [“NOP”]), on the one hand, and ADAMAS PHARMACEUTICALS, INC., a Delaware corporation (formerly known as Neuromolecular Pharmaceuticals, Inc.) (“Tenant”), on the other hand, with respect to the following:
LICENSE AGREEMENT BY AND BETWEEN FOREST LABORATORIES HOLDINGS LIMITED AND ADAMAS PHARMACEUTICALS, INC. DATED AS OF NOVEMBER 13, 2012License Agreement • March 5th, 2014 • Adamas Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT is entered into this 13th day of November, 2012 (the “Effective Date”), by and between Forest Laboratories Holdings Limited, a corporation organized under the laws of the Republic of Ireland, having a business address at Cumberland House, 9th Floor, 1 Victoria Street, Hamilton HM11, Bermuda (“Forest”), an indirect, wholly owned subsidiary of Forest Laboratories, Inc. (“Forest Parent”), and Adamas Pharmaceuticals, Inc., a corporation organized under the laws of the State of Delaware, having a business address at 2200 Powell Street, Suite 220, Emeryville, California 94608 (“Adamas”).
FOURTH AMENDMENT TO LEASELease Agreement • March 5th, 2014 • Adamas Pharmaceuticals Inc • Pharmaceutical preparations
THIS FOURTH AMENDMENT TO LEASE (“Amendment”), dated for reference purposes only as of the; 31st day of January, 2013, is entered into by and between EMERYVILLE OFFICE, L.L.C., a Delaware limited liability company (“Landlord”), and ADAMAS PHARMACEUTICALS, INC., a Delaware corporation (formerly known as Neuromolecular Pharmaceuticals, Inc.) (“Tenant”).
